Rezpegaldesleukin Shows Sustained Benefit in Moderate-to-Severe Atopic Dermatitis in Phase 2 b trial
The phase 2b REZOLVE-AD trial enrolled 393 adults with moderate-to-severe atopic dermatitis across approximately 110 global ...
Dr. David Hauswirth answers the question: 'Atopic Dermatitis Versus Eczema?' — -- Question: What is atopic dermatitis and is it different from eczema? (What causes it and is it contagious?) ...
The core symptoms of atopic dermatitis — dry and cracked skin, itchiness, rashes on swollen skin, and oozing, crusting irritated skin — can appear anywhere on the body. The exact symptoms and severity ...
Atopic dermatitis is associated with increased asthma and rhinitis worldwide, according to new global estimates. Learn more.
The FDA has approved topical difamilast for treating mild-to-moderate atopic dermatitis (AD) in adults and children aged 2 years or older, according to a press release from the manufacturer, Acrotech ...
In spite of its commonality, there are still plenty of unknowns around atopic dermatitis, including the actual cause of the skin condition. Perhaps that’s why there are so many myths surrounding it.
Recently published Atopic Dermatitis Market Insights report includes a comprehensive understanding of current treatment ...
Researchers have found in a new study that there is no general association between atopic dermatitis (AD) and contact ...
Elaine Siegfried, MD: Are the terms atopic dermatitis and eczema interchangeable? They are, they are synonyms, except for atopic dermatitis is a very specific kind of eczema. Eczema and dermatitis are ...
Adults with atopic dermatitis and chronic hand eczema saw early and sustained improvements in skin and quality of life measures with tralokinumab compared with placebo, according to a poster presented ...
Atopic dermatitis is a chronic (long-lasting) skin condition that causes dry, itchy patches of skin that may crack or ooze. It is the most common form of eczema. Itchiness occurs when an overactive ...
Apogee Therapeutics develops biologic therapies targeting dermatology and respiratory conditions, with lead candidates in clinical trials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results